1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The link for this program now points to a previous cycle.
Historical funding: Not specified
Prior eligibility: Open to a wide range of applicants, including institutions of higher education, non-profits, small businesses, and foreign organizations.
Translational and Clinical Studies on the Microbiome and Pro/Prebiotics (FOA) is sponsored by National Institutes of Health (NIH). This funding opportunity aims to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for probiotic/prebiotic components and combinations, and to understand their underlying mechanisms of action and variability in responses.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article